O=C1[C@@H]2CN3CN(c4ccccc4)N=C(c4ccccc4)[C@@]3(c3ccccc3)[C@@H]2C(=O)N1c1ccccc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?